Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-03 9:30 pm Sale |
2025-03-03 | 13D | BeiGene, Ltd. ONC |
HHLR Advisors, Ltd. | 92,805,741 6.700% |
-32,240,000 (-25.78%) |
Filing History |
| 2025-02-14 4:05 pm Sale |
2024-12-31 | 13G | Agora, Inc. API |
HHLR Advisors, Ltd. | 8,394,212 2.300% |
-10,893,088 (-56.48%) |
Filing History |
| 2024-12-04 4:05 pm Sale |
2024-12-02 | 13D | BeiGene, Ltd. ONC |
HHLR Advisors, Ltd. | 125,045,741 9.000% |
-21,997,317 (-14.96%) |
Filing History |
| 2024-11-14 4:34 pm Purchase |
2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS |
HHLR Advisors, Ltd. | 125,069 4.000% |
125,069 (New Position) |
Filing History |
| 2024-11-14 4:33 pm Purchase |
2024-09-30 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
HHLR Advisors, Ltd. | 4,484,672 13.400% |
4,484,672 (New Position) |
Filing History |
| 2024-11-14 4:32 pm Purchase |
2024-09-30 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
HHLR Advisors, Ltd. | 1,582,635 3.900% |
1,582,635 (New Position) |
Filing History |
| 2024-02-14 4:41 pm Sale |
2023-12-31 | 13G | Smart Share Global Limited EM |
HHLR Advisors, Ltd. | 62,367,293 14.000% |
-260,600 (-0.42%) |
Filing History |
| 2024-02-14 4:39 pm Purchase |
2023-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
HHLR Advisors, Ltd. | 3,879,426 9.900% |
338,125 (+9.55%) |
Filing History |
| 2024-02-14 4:39 pm Sale |
2023-12-31 | 13G | Cytek Biosciences, Inc. CTKB |
HHLR Advisors, Ltd. | 6,657,030 4.900% |
-2,027,500 (-23.35%) |
Filing History |
| 2024-02-14 4:37 pm Purchase |
2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
HHLR Advisors, Ltd. | 238,857 8.200% |
146,466 (+158.53%) |
Filing History |
| 2024-02-14 4:36 pm Sale |
2023-12-31 | 13G | MOGU Inc. MOGU |
HHLR Advisors, Ltd. | 254,253,005 11.800% |
-6,921,000 (-2.65%) |
Filing History |
| 2024-02-14 4:35 pm Sale |
2023-12-31 | 13G | Bright Scholar Education Holdings Limited BEDU |
HHLR Advisors, Ltd. | 3,952,572 12.600% |
-33,224 (-0.83%) |
Filing History |
| 2024-02-14 4:35 pm Sale |
2023-12-31 | 13G | Agora, Inc. API |
HHLR Advisors, Ltd. | 19,287,300 5.100% |
-712,700 (-3.56%) |
Filing History |
| 2023-08-18 4:32 pm Purchase |
2022-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
HHLR Advisors, Ltd. | 3,541,301 9.900% |
917,377 (+34.96%) |
Filing History |
| 2023-06-30 4:05 pm Sale |
2023-06-28 | 13D | I-Mab IMAB |
HHLR Advisors, Ltd. | 15,891,211 8.300% |
-629,349 (-3.81%) |
Filing History |
| 2023-02-14 4:14 pm Purchase |
2023-02-14 | 13D | BeiGene, Ltd. ONC |
HHLR Advisors, Ltd. | 147,043,058 10.900% |
7,800 (+0.01%) |
Filing History |
| 2023-02-14 4:13 pm Sale |
2022-12-31 | 13G | On Holding AG ONON |
HHLR Advisors, Ltd. | 5,468,504 1.900% |
-10,505,246 (-65.77%) |
Filing History |
| 2023-02-14 4:13 pm Sale |
2022-12-31 | 13G | Root, Inc. ROOT |
HHLR Advisors, Ltd. | 138,977 1.500% |
-254,768 (-64.70%) |
Filing History |
| 2023-02-14 4:10 pm Sale |
2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
HHLR Advisors, Ltd. | 92,391 5.800% |
-2,212 (-2.34%) |
Filing History |
| 2023-02-14 4:09 pm Sale |
2022-12-31 | 13G | Cytek Biosciences, Inc. CTKB |
HHLR Advisors, Ltd. | 8,684,530 6.400% |
-72,500 (-0.83%) |
Filing History |